Yang, M., Liang, Y., Wang, G., Fang, B., Wang, L., Jiang, S., Wang, Y., Mei, H., Yang, W., He, Y., Wang, W., Zhang, H., Wang, H., Jin, J., Chen, W. (2025). A phase I monotherapy study assessing the safety and efficacy of GR1803, a BCMAƗCD3 bispecific antibody, in patients with relapsed/refractory multiple myeloma. Blood. https://doi.org/10.1182/blood-2025-5822